SCHEMBL19337478

SCHEMBL19337478

C=Nc1ccc(C)cc1CCC

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TSHR P16473 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ AMY1A P0DUB6 1/20 0.32
▸ CYP3A4 P08684 1/20 0.31
▸ ADRA2A P08913 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ LDHA P00338 1/20 0.30
▸ LDHB P07195 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2A6 P11509 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21227827 0.85 TAAR1 (0.33) TAAR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL24365379 0.76 — —
SCHEMBL25859426 0.76 — —
SCHEMBL1069010 0.74 TAAR1 (0.41) TAAR1ALDH1A1POLBMAPTGPR55
SCHEMBL18597323 0.74 CYP3A4 (0.42) TAAR1ALDH1A1CYP3A4ADRA2A
SCHEMBL22791511 0.73 CYP3A4 (0.39) ALDH1A1MAPTTSHRCYP3A4CYP1A2
SCHEMBL26688291 0.73 TAAR1 (0.43) TAAR1MAPTMEN1KMT2ANPC1
SCHEMBL10822849 0.73 TAAR1 (0.43) TAAR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL2045305 0.73 TAAR1 (0.65) TAAR1ALDH1A1POLBKMT2ATSHR
SCHEMBL9629541 0.71 TAAR1 (0.42) TAAR1ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2906552-B1 GUANIDINE SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-11-22 — — EP disclosed
EP-2297133-B1 1, 2 DISUBSTITUTED HETEROCYCLIC COMPOUNDS FORUM PHARMACEUTICALS INC (US) 2017-09-13 — — EP disclosed
Send feedback